MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 110 filers reported holding MYOVANT SCIENCES LTD in Q2 2021. The put-call ratio across all filers is 4.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $487,005 | -56.8% | 18,064 | -71.2% | 0.00% | – |
| Q3 2022 | $1,127,000 | +104.5% | 62,764 | +41.6% | 0.00% | – |
| Q2 2022 | $551,000 | -69.5% | 44,321 | -67.3% | 0.00% | – |
| Q1 2022 | $1,807,000 | -4.4% | 135,597 | +11.6% | 0.00% | – |
| Q4 2021 | $1,891,000 | -8.2% | 121,473 | +32.3% | 0.00% | – |
| Q3 2021 | $2,060,000 | -58.9% | 91,782 | -58.3% | 0.00% | -100.0% |
| Q2 2021 | $5,017,000 | +48.1% | 220,293 | +33.8% | 0.00% | 0.0% |
| Q1 2021 | $3,388,000 | -38.6% | 164,655 | -17.6% | 0.00% | -33.3% |
| Q4 2020 | $5,517,000 | +50.8% | 199,740 | -23.3% | 0.00% | +50.0% |
| Q3 2020 | $3,659,000 | +67.8% | 260,423 | +146.1% | 0.00% | +100.0% |
| Q2 2020 | $2,181,000 | +483.2% | 105,800 | +338.2% | 0.00% | 0.0% |
| Q4 2019 | $374,000 | – | 24,145 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 65,000 | $808,000 | 1.13% |
| Bellevue Group AG | 5,919,639 | $73,581,000 | 1.04% |
| Rhenman & Partners Asset Management AB | 310,000 | $3,853,000 | 0.44% |
| Hennion & Walsh Asset Management, Inc. | 279,335 | $3,472,000 | 0.22% |
| TORRAY INVESTMENT PARTNERS LLC | 81,621 | $1,015,000 | 0.19% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 302,120 | $3,755,000 | 0.14% |
| Virtus ETF Advisers LLC | 22,356 | $278,000 | 0.10% |
| Tarbox Family Office, Inc. | 27,500 | $342,000 | 0.08% |
| BOURGEON CAPITAL MANAGEMENT LLC | 15,200 | $189,000 | 0.05% |
| JANUS HENDERSON GROUP PLC | 5,449,107 | $67,735,000 | 0.05% |